Product Name
LDLRAP1, Polyclonal Antibody
Full Product Name
LDLRAP1 Polyclonal Antibody
Product Synonym Names
ARH; ARH1; ARH2; FHCB1; FHCB2
Product Gene Name
anti-LDLRAP1 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Purity/Purification
Affinity Purification
Immunogen
Recombinant protein of human LDLRAP1
Buffer
PBS with 0.02% sodium azide, 50% glycerol, pH7.3
Santa Cruz Alternative
Potential replacement for Santa Cruz Biotechnology antibody catalog# sc-26734 / sc-130692 / sc-292294
Preparation and Storage
Store at -20 degree C (regular) or -80 degree C (long term). Avoid freeze / thaw cycles. Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Other Notes
Small volumes of anti-LDLRAP1 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-LDLRAP1 antibody
The protein encoded by this gene is a cytosolic protein which contains a phosphotyrosine binding (PTD) domain. The PTD domain has been found to interact with the cytoplasmic tail of the LDL receptor. Mutations in this gene lead to LDL receptor malfunction and cause the disorder autosomal recessive hypercholesterolaemia.
Applications Tested/Suitable for anti-LDLRAP1 antibody
Western Blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)
Application Notes for anti-LDLRAP1 antibody
WB: 1:500-1:2000, IHC: 1:50-1:200, IF: 1:50-100
Immunofluorescence (IF) of anti-LDLRAP1 antibody
Immunofluorescence analysis of A549 cell using LDLRAP1 antibody.

NCBI/Uniprot data below describe general gene information for LDLRAP1. It may not necessarily be applicable to this product.
NCBI Accession #
NP_056442.2
[Other Products]
NCBI GenBank Nucleotide #
NM_015627.2
[Other Products]
UniProt Secondary Accession #
Q6TQS9; Q8N2Y0; Q9UFI9; A2BHI5[Other Products]
UniProt Related Accession #
Q5SW96[Other Products]
Molecular Weight
Calculated MW: 34kDa
NCBI Official Full Name
low density lipoprotein receptor adapter protein 1
NCBI Official Synonym Full Names
low density lipoprotein receptor adaptor protein 1
NCBI Official Symbol
LDLRAP1??[Similar Products]
NCBI Official Synonym Symbols
ARH; ARH1; ARH2; FHCB1; FHCB2
??[Similar Products]
NCBI Protein Information
low density lipoprotein receptor adapter protein 1
UniProt Protein Name
Low density lipoprotein receptor adapter protein 1
UniProt Synonym Protein Names
Autosomal recessive hypercholesterolemia protein
Protein Family
Low density lipoprotein receptor adapter protein
UniProt Gene Name
LDLRAP1??[Similar Products]
UniProt Synonym Gene Names
ARH??[Similar Products]
UniProt Entry Name
ARH_HUMAN
NCBI Summary for LDLRAP1
The protein encoded by this gene is a cytosolic protein which contains a phosphotyrosine binding (PTD) domain. The PTD domain has been found to interact with the cytoplasmic tail of the LDL receptor. Mutations in this gene lead to LDL receptor malfunction and cause the disorder autosomal recessive hypercholesterolaemia. [provided by RefSeq, Jul 2008]
UniProt Comments for LDLRAP1
LDLRAP1: Adapter protein (clathrin-associated sorting protein (CLASP)) required for efficient endocytosis of the LDL receptor (LDLR) in polarized cells such as hepatocytes and lymphocytes, but not in non-polarized cells (fibroblasts). May be required for LDL binding and internalization but not for receptor clustering in coated pits. May facilitate the endocytocis of LDLR and LDLR-LDL complexes from coated pits by stabilizing the interaction between the receptor and the structural components of the pits. May also be involved in the internalization of other LDLR family members. Binds to phosphoinositides, which regulate clathrin bud assembly at the cell surface. Defects in LDLRAP1 are the cause of autosomal recessive hypercholesterolemia (ARH). ARH is a disorder caused by defective internalization of LDL receptors (LDLR) in the liver. ARH has the clinical features of familial hypercholesterolemia (FH) homozygotes, including severely elevated plasma LDL cholesterol, tuberous and tendon xanthomata, and premature atherosclerosis. LDL receptor (LDLR) activity measured in skin fibroblasts is normal, as the LDL binding ability.
Chromosomal Location of Human Ortholog: 1p36.11
Cellular Component: AP-1 adaptor complex; AP-2 adaptor complex; axon; basal plasma membrane; cytosol; early endosome; internal side of plasma membrane; neurofilament; recycling endosome
Molecular Function: beta-amyloid binding; clathrin binding; low-density lipoprotein receptor binding; phosphatidylinositol-4,5-bisphosphate binding; phosphotyrosine binding; protein binding; receptor signaling complex scaffold activity
Biological Process: amyloid precursor protein metabolic process; cholesterol homeostasis; cholesterol metabolic process; positive regulation of receptor-mediated endocytosis; positive regulation of signal transduction; receptor internalization; receptor-mediated endocytosis; regulation of protein binding; transport
Disease: Hypercholesterolemia, Autosomal Recessive
Research Articles on LDLRAP1
1. Numb specifically regulates NPC1L1-mediated cholesterol absorption both in human intestine and liver, distinct from ARH and Dab2, which selectively participate in LDLR-mediated LDL uptake.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.